☰

Shang Su - Publications

Affiliations: 
The University of Toledo College of Medicine and Life Sciences 
Area:
prostate cancer, bone metastasis, tumor dormancy
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Liu R, Su S, Xing J, Liu K, Zhao Y, Stangis M, Jacho DP, Yildirim-Ayan ED, Gatto-Weis CM, Chen B, Li X. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase. Journal of Experimental & Clinical Cancer Research : Cr. 42: 264. PMID 37821954 DOI: 10.1186/s13046-023-02849-0  0.355
2023 Zhao Y, Su S, Li X. Parathyroid Hormone-Related Protein/Parathyroid Hormone Receptor 1 Signaling in Cancer and Metastasis. Cancers. 15. PMID 37046642 DOI: 10.3390/cancers15071982  0.394
2021 Su S, Li X. Dive into Single, Seek Out Multiple: Probing Cancer Metastases via Single-Cell Sequencing and Imaging Techniques. Cancers. 13. PMID 33802312 DOI: 10.3390/cancers13051067  0.368
2019 Su S, Yang Z, Gao H, Yang H, Zhu S, An Z, Wang J, Li Q, Chandarlapaty S, Deng H, Wu W, Rao Y. Potent and Preferential Degradation of CDK6 via PROteolysis TArgeting Chimera Degraders. Journal of Medicinal Chemistry. PMID 31330105 DOI: 10.1021/Acs.Jmedchem.9B00871  0.397
2019 An Z, Lv W, Su S, Wu W, Rao Y. Correction to: Developing potent PROTACs tools for selective degradation of HDAC6 protein. Protein & Cell. PMID 30796636 DOI: 10.1007/S13238-019-0613-4  0.302
2019 An Z, Lv W, Su S, Wu W, Rao Y. Developing potent PROTACs tools for selective degradation of HDAC6 protein. Protein & Cell. PMID 30603959 DOI: 10.1007/S13238-018-0602-Z  0.303
2018 Zhao Q, Lan T, Su S, Rao Y. Induction of apoptosis in MDA-MB-231 breast cancer cells by a PARP1-targeting PROTAC small molecule. Chemical Communications (Cambridge, England). PMID 30540295 DOI: 10.1039/C8Cc07813K  0.335
2014 Ding Y, Su S, Tang W, Zhang X, Chen S, Zhu G, Liang J, Wei W, Guo Y, Liu L, Chen YG, Wu W. Enrichment of the β-catenin-TCF complex at the S and G2 phases ensures cell survival and cell cycle progression. Journal of Cell Science. 127: 4833-45. PMID 25236602 DOI: 10.1242/Jcs.146977  0.308
Show low-probability matches.